NO920051L - Farmasoeytisk sammensetning for slanking - Google Patents
Farmasoeytisk sammensetning for slankingInfo
- Publication number
- NO920051L NO920051L NO92920051A NO920051A NO920051L NO 920051 L NO920051 L NO 920051L NO 92920051 A NO92920051 A NO 92920051A NO 920051 A NO920051 A NO 920051A NO 920051 L NO920051 L NO 920051L
- Authority
- NO
- Norway
- Prior art keywords
- slimming
- pharmaceutical composition
- ephedrine
- human
- reducing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
En farmasøytisk sammensetning for behandling av overvekt og fettsyke eller komplikasjoner derav, idet sammensetningen omfatter en kombinasjon av en adrenerg 6 agonist og et xantin, for eksempel en kombinasjon av efedrin og kaffein, i et vektforhold fra omtrent 1:8 til omtrent 1:24, beregnet (når e agonlsten ikke er L-efedrin) på den isotermogene mengden av L-efedrin og (når xantin ikke er kaffein) på den isotermogene mengden av kaffein for å oppnå en supra-addltiv termogen virkning i kroppen etter oral, rektal, nasal eller parenteral administrasjon, er beskrevet. Sammensetningen kan videre'bli anvendt i et husdyr for å forbedre kroppens innhold av kjått på bekostning av kroppens innhold av fett.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK339289A DK339289D0 (da) | 1989-07-07 | 1989-07-07 | Farmaceutisk praeparat |
PCT/DK1990/000106 WO1991000730A1 (en) | 1989-07-07 | 1990-04-20 | A slimming pharmaceutical composition |
Publications (2)
Publication Number | Publication Date |
---|---|
NO920051D0 NO920051D0 (no) | 1992-01-03 |
NO920051L true NO920051L (no) | 1992-01-31 |
Family
ID=8122369
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO92920051A NO920051L (no) | 1989-07-07 | 1992-01-03 | Farmasoeytisk sammensetning for slanking |
Country Status (19)
Country | Link |
---|---|
US (1) | US5422352A (no) |
EP (1) | EP0480934B1 (no) |
JP (1) | JP2584899B2 (no) |
KR (1) | KR0159045B1 (no) |
AT (1) | ATE107858T1 (no) |
AU (1) | AU638992B2 (no) |
CA (1) | CA2063598C (no) |
DE (1) | DE69010336T2 (no) |
DK (2) | DK339289D0 (no) |
ES (1) | ES2055911T3 (no) |
FI (1) | FI920026A0 (no) |
HK (1) | HK1001821A1 (no) |
HU (1) | HU220071B (no) |
LT (1) | LT3536B (no) |
LV (1) | LV10192B (no) |
NO (1) | NO920051L (no) |
RU (1) | RU2109511C1 (no) |
UA (1) | UA27779C2 (no) |
WO (1) | WO1991000730A1 (no) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5865869A (en) * | 1991-08-02 | 1999-02-02 | Ecologel Usa, Inc. | Solution for plant root watering |
WO1994000432A1 (en) * | 1992-06-30 | 1994-01-06 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Anorectic epinephrine derivatives |
WO1994008609A1 (en) * | 1992-10-15 | 1994-04-28 | Dana-Farber Cancer Institute, Inc. | TREATMENT OF INSULIN RESISTANCE IN OBESITY LINKED TYPE II DIABETES USING ANTAGONISTS TO TNF-α FUNCTION |
ES2094687B1 (es) * | 1994-08-02 | 1997-12-16 | S A L V A T Lab Sa | Combinacion farmaceutica contra la obesidad o el sobrepeso. |
FR2746644A1 (fr) * | 1996-03-18 | 1997-10-03 | Firion Jackie | Produit parapharmaceutique moderateur d'appetit |
US6224873B1 (en) | 1996-09-30 | 2001-05-01 | Zhishin, Llc | Regulation of appetite, body weight and athletic function with materials derived from citrus varieties |
DE69638106D1 (de) * | 1996-09-30 | 2010-02-11 | Dennis Jones | Regulation von Körpergewicht durch Materialien basierend auf Zitrusvariationen |
PT946155E (pt) * | 1996-12-23 | 2006-07-31 | Sla Pharma Ag | Composicao farmaceutica para tratar incontinencia fecal e prurido anal |
US5798101A (en) * | 1997-01-22 | 1998-08-25 | Hpf, L.L.C. | Herbal appetite suppressant and weight loss composition |
US5985282A (en) * | 1997-01-22 | 1999-11-16 | Hpf, L.L.C. | Herbal appetite suppressant and weight loss composition |
US6162455A (en) * | 1997-01-22 | 2000-12-19 | American Cyanamid Company | Method for increasing lean meat, improving the lean meat to fat ratio and improving amino acid utilization in warm-blooded animals |
HUP9700654A2 (hu) | 1997-03-26 | 1999-09-28 | Dezső Korbonits | Teobromin tartalmú köhögéscsillapító készítmények |
US6468519B1 (en) * | 1997-09-10 | 2002-10-22 | Rutgers, The State University Of New Jersey | Polyanhydrides with biologically active degradation products |
US7232830B2 (en) | 1998-06-26 | 2007-06-19 | Elaine A Delack | Method for treatment of neurodegenerative diseases and effects of aging |
CA2336004C (en) | 1998-06-26 | 2006-10-24 | Elaine A. Delack | Use of histamine h2 agonists for the treatment of multiple sclerosis |
US6340482B1 (en) | 2000-05-18 | 2002-01-22 | Zhishin, Llc | Methods for inducing weight loss in a human with materials derived from Citrus varieties |
US6113949A (en) * | 1998-10-27 | 2000-09-05 | Prolab Nutrition, Inc. | Weight control product and method of treating hyperlipidemia and increasing vigor with said product |
US6475514B1 (en) * | 1998-12-03 | 2002-11-05 | Andrew Blitzer | Athletic patch |
US6576272B1 (en) * | 1999-03-05 | 2003-06-10 | Twin Laboratories Incorporated | Dietary supplement and method of using same |
AU6221500A (en) * | 1999-07-20 | 2001-02-05 | Natrol, Inc. | Weight control product comprising a synergistic mixture of guggul extract, phosphate salt and metabolic stimulant |
MXPA02001882A (es) * | 1999-08-23 | 2002-08-20 | Univ Tulane | Modulacion del transportador de leptina a traves de la barrera hemato-encefalica. |
US6723737B1 (en) * | 1999-10-20 | 2004-04-20 | Eliezer Rapaport | Methods, pharmaceutical and therapeutic compostions for administering adenosine |
US7115297B2 (en) * | 2000-02-22 | 2006-10-03 | Suzanne Jaffe Stillman | Nutritionally fortified liquid composition with added value delivery systems/elements/additives |
US8178150B2 (en) | 2000-02-22 | 2012-05-15 | Suzanne Jaffe Stillman | Water containing soluble fiber |
US7892586B2 (en) | 2001-02-22 | 2011-02-22 | Suzanne Jaffe Stillman | Water containing soluble fiber |
DE10011541A1 (de) * | 2000-03-06 | 2001-09-20 | Reimann Hartmut | Verwendung einer Kombination aus Ephedrin und Coffein und/oder Theophyllin zur Vitalisierung von Knochenfischen, Wasserzusatz zur Vitalisierung von Knochenfischen |
US6316499B1 (en) | 2000-05-18 | 2001-11-13 | Zhishin, Llc | Methods for increasing the muscle mass of a human with materials derived from citrus varieties |
CN1406131A (zh) * | 2000-12-25 | 2003-03-26 | 株式会社资生堂 | 活化交感神经的香料组合物 |
US7048941B2 (en) * | 2001-03-30 | 2006-05-23 | New World Enterprizes, Inc. | Chocolate composition as delivery system for nutrients and medications |
WO2003022239A2 (en) * | 2001-09-07 | 2003-03-20 | Western Holdings Llc | Stable water in oil aminophylline emulsions |
GB0130763D0 (en) | 2001-12-21 | 2002-02-06 | Norgine Res Ltd | Treatment methods |
WO2003088953A2 (en) * | 2002-04-19 | 2003-10-30 | N.V. Nutricia | Multiphasic diet |
US8142810B2 (en) * | 2002-05-30 | 2012-03-27 | The Procter & Gamble Company | Dietary method for modulating glucose metabolism and associated conditions and increasing longevity |
US20040077530A1 (en) * | 2002-10-18 | 2004-04-22 | Robert Portman | Composition for reducing caloric intake |
US20040224031A1 (en) * | 2003-05-06 | 2004-11-11 | Antonio Zorzano Olarte | Combination of amines and vanadium (IV)/(V) compounds for the treatment and/or prevention of diabetes mellitus |
JP2007508329A (ja) * | 2003-10-17 | 2007-04-05 | ダイエット・フォーミュレイションズ・リミテッド | 体重減少用サプリメント |
WO2005051092A2 (en) * | 2003-11-20 | 2005-06-09 | Alteragon Pty Ltd | Method of decreasing fat deposits and body weight in mammals and birds |
CA2455248A1 (en) * | 2004-01-29 | 2005-07-29 | Alexander Zolotoy | Oral administration of r-albuterol against obesity |
US7524064B2 (en) * | 2004-03-09 | 2009-04-28 | Research Foundation Of The State University Of New York | Apparatus and method for assessing retinal damage |
US20060074057A1 (en) * | 2004-10-04 | 2006-04-06 | Eric Marchewitz | Use of chenodeoxycholic acid for reducing adipose tissue |
US20060134230A1 (en) * | 2004-12-17 | 2006-06-22 | Sal Abraham | Weight loss composition and formulation |
US20060204599A1 (en) * | 2005-03-14 | 2006-09-14 | Wheat Jared R | Dietary supplement and method of using same |
US20090214682A1 (en) * | 2008-02-22 | 2009-08-27 | Heuer Marvin A | Composition and methods for weight loss in a subject |
US9044606B2 (en) | 2010-01-22 | 2015-06-02 | Ethicon Endo-Surgery, Inc. | Methods and devices for activating brown adipose tissue using electrical energy |
WO2012092056A1 (en) * | 2010-12-29 | 2012-07-05 | Ethicon Endo-Surgery, Inc. | Methods and devices for activating brown adipose tissue with targeted substance delivery |
IN2015DN03188A (no) | 2012-10-08 | 2015-10-02 | Rivalea Australia Pty Ltd | |
US9877434B2 (en) | 2013-05-30 | 2018-01-30 | Ecologel Solutions, Llc | Granular compositions and methods for drought mitigation |
BR112016022039A2 (pt) * | 2014-03-26 | 2017-08-15 | Rivalea Australia Pty Ltd | Método para aprimorar eficácia de alimentação em ruminantes |
US10092738B2 (en) | 2014-12-29 | 2018-10-09 | Ethicon Llc | Methods and devices for inhibiting nerves when activating brown adipose tissue |
US10080884B2 (en) | 2014-12-29 | 2018-09-25 | Ethicon Llc | Methods and devices for activating brown adipose tissue using electrical energy |
AU2016219070B2 (en) | 2015-02-13 | 2020-06-11 | Mars, Incorporated | Pet food feeding system |
WO2016167855A1 (en) * | 2015-04-14 | 2016-10-20 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Combination of albuterol and caffeine as synergistic treatment for obesity or sarcopenia |
GB201522296D0 (en) | 2015-12-17 | 2016-02-03 | Mars Inc | Food product to reduce body fat |
CA3140043A1 (en) | 2019-05-16 | 2020-11-19 | Nexus Pharmaceuticals, Inc. | Compositions comprising ephedrine or an ephedrine salt and methods of making and using same |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2390164A1 (fr) * | 1977-05-13 | 1978-12-08 | Blanie Paul | Association a action anti-asthmatique |
FI772858A (fi) * | 1977-06-03 | 1978-12-04 | Pharmaceutical Export Promotio | Avmagningsmedel och foerfarande foer framstaellning daerav |
US4364922A (en) * | 1980-10-14 | 1982-12-21 | University Of Virginia Alumni Patents Foundation | Adenosine antagonists in the treatment and diagnosis of A-V node conduction disturbances |
US4525359A (en) * | 1982-12-10 | 1985-06-25 | Greenway Frank L Iii | Treatment for selective weight control |
US5011843A (en) * | 1988-05-31 | 1991-04-30 | Iolab Corporation | Treatment of glaucoma using phosphodiesterase inhibitors |
-
1989
- 1989-07-07 DK DK339289A patent/DK339289D0/da not_active Application Discontinuation
-
1990
- 1990-04-20 DK DK90907185.4T patent/DK0480934T3/da active
- 1990-04-20 HU HU9200051A patent/HU220071B/hu unknown
- 1990-04-20 UA UA93004254A patent/UA27779C2/uk unknown
- 1990-04-20 RU SU5010984A patent/RU2109511C1/ru not_active IP Right Cessation
- 1990-04-20 KR KR1019920700029A patent/KR0159045B1/ko not_active IP Right Cessation
- 1990-04-20 ES ES90907185T patent/ES2055911T3/es not_active Expired - Lifetime
- 1990-04-20 CA CA002063598A patent/CA2063598C/en not_active Expired - Fee Related
- 1990-04-20 AU AU56308/90A patent/AU638992B2/en not_active Ceased
- 1990-04-20 WO PCT/DK1990/000106 patent/WO1991000730A1/en active IP Right Grant
- 1990-04-20 JP JP2507158A patent/JP2584899B2/ja not_active Expired - Fee Related
- 1990-04-20 DE DE69010336T patent/DE69010336T2/de not_active Expired - Fee Related
- 1990-04-20 EP EP90907185A patent/EP0480934B1/en not_active Expired - Lifetime
- 1990-04-20 AT AT90907185T patent/ATE107858T1/de not_active IP Right Cessation
-
1992
- 1992-01-03 NO NO92920051A patent/NO920051L/no unknown
- 1992-01-03 FI FI920026A patent/FI920026A0/fi not_active Application Discontinuation
- 1992-12-21 US US07/996,840 patent/US5422352A/en not_active Expired - Fee Related
-
1993
- 1993-02-03 LV LVP-93-94A patent/LV10192B/en unknown
- 1993-06-23 LT LTIP702A patent/LT3536B/lt not_active IP Right Cessation
-
1998
- 1998-01-21 HK HK98100528A patent/HK1001821A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2109511C1 (ru) | 1998-04-27 |
LV10192A (lv) | 1994-10-20 |
JPH04507091A (ja) | 1992-12-10 |
UA27779C2 (uk) | 2000-10-16 |
HK1001821A1 (en) | 1998-07-10 |
AU638992B2 (en) | 1993-07-15 |
KR0159045B1 (ko) | 1998-12-01 |
CA2063598A1 (en) | 1991-01-08 |
HU9200051D0 (en) | 1992-06-29 |
LTIP702A (en) | 1995-01-31 |
US5422352A (en) | 1995-06-06 |
LT3536B (en) | 1995-11-27 |
DK339289D0 (da) | 1989-07-07 |
NO920051D0 (no) | 1992-01-03 |
HUT62798A (en) | 1993-06-28 |
EP0480934B1 (en) | 1994-06-29 |
DE69010336T2 (de) | 1994-11-03 |
JP2584899B2 (ja) | 1997-02-26 |
LV10192B (en) | 1995-06-20 |
HU220071B (hu) | 2001-10-28 |
FI920026A0 (fi) | 1992-01-03 |
EP0480934A1 (en) | 1992-04-22 |
DK0480934T3 (da) | 1994-11-07 |
CA2063598C (en) | 1997-12-09 |
ATE107858T1 (de) | 1994-07-15 |
ES2055911T3 (es) | 1994-09-01 |
WO1991000730A1 (en) | 1991-01-24 |
AU5630890A (en) | 1991-02-06 |
DE69010336D1 (de) | 1994-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO920051L (no) | Farmasoeytisk sammensetning for slanking | |
YU47543B (sh) | Postupak za dobijanje farmaceutskog preparata za stimulaciju granulocita | |
ES2162615T3 (es) | Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina. | |
DE69738000D1 (de) | Neue Arzneiformulierung enthaltend Budesonide | |
PT977564E (pt) | Forscolina para promocao da massa corporal magra | |
DE68910159D1 (de) | Dosierform für Verabreichung in der Humanmedizin. | |
SE9301290D0 (sv) | Anvaendning av en somatostatinanalog | |
BE898749A (fr) | Nouveau procede de preparation de formes galeniques utiles notamment en therapeutique, dietetique, cosmetique et diagnostic | |
DE3650358D1 (de) | Diphosphonate enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Arthrosis. | |
EP0214254A1 (en) | MELATONIN COMPOSITIONS AND USES THEREOF. | |
ES2176495T3 (es) | Utilizacion de un antagonista de la bradiquinina, destinada a inducir y/o estimular el crecimiento de los cabellos y/o frenar su caida. | |
BR9911237A (pt) | Novo uso de um derivado de piridazinona | |
KR900007434A (ko) | 시스타틴을 유효 성분으로하는 치료제 | |
IT8026233A0 (it) | Derivato della n-acetil-cisteina ad attivita' terapeutica, procedimento per la sua preparazione e relative composizioni farmaceutiche. | |
IT8423896A0 (it) | Diacilderivati della glicerilfosforilcolina ad attivita' terapeutica, procedimento per laloro preparazione e relative composizioni farmaceutiche. | |
HUP9903679A2 (hu) | Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására | |
AR008155A1 (es) | Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres. | |
GB2004183A (en) | Compositions containing caffeine and ephedrine or their derivatives | |
KR900017599A (ko) | 종양 치료용 약학 조성물 | |
ATE72397T1 (de) | Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit. | |
RU94002713A (ru) | Способ лечения детей с синдромом удлиненного интервала qт (романо-уорда) | |
ATE350026T1 (de) | Erhaltung von körpereigenen proteinen | |
RU96122371A (ru) | Способ лечения эндогенных и послеоперационных увеитов | |
FR2418226A1 (fr) | Methoxy-2 alkylthio-5 benzamides et leur application en therapeutique | |
ES468750A1 (es) | Un metodo para preparar una composicion veterinaria que com-prende trimetoprim y sulfaquinoxalina |